Clinical Trial Update: TissueLink Versus SEAMGUARD After Distal Pancreatectomy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing TissueLink versus SEAMGUARD after distal pancreatectomy; study terminated with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Pancreatectomy

Drugs mentioned

• Seamguard
• TissueLink

Snippet

Sponsor: Mayo Clinic | Conditions: Distal Pancreatectomy | Phase 4 | Status: TERMINATED | Results posted: 2015-06-12